Y-mAbs Therapeutics, Inc. (YMAB) Now Trades Above Golden Cross: Time to Buy?

01.09.25 15:55 Uhr

Werte in diesem Artikel

After reaching an important support level, Y-mAbs Therapeutics, Inc. (YMAB) could be a good stock pick from a technical perspective. YMAB recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.A golden cross is a technical chart pattern that can signify a potential bullish breakout. It's formed from a crossover involving a security's short-term moving average breaking above a longer-term moving average, with the most common moving averages being the 50-day and the 200-day, since bigger time periods tend to form stronger breakouts.There are three stages to a golden cross. First, there must be a downtrend in a stock's price that eventually bottoms out. Then, the stock's shorter moving average crosses over its longer moving average, triggering a positive trend reversal. The third stage is when a stock continues the upward momentum to higher prices.A golden cross contrasts with a death cross, another widely-followed chart pattern that suggests bearish momentum could be on the horizon.YMAB has rallied 88.7% over the past four weeks, and the company is a #2 (Buy) on the Zacks Rank at the moment. This combination indicates YMAB could be poised for a breakout.The bullish case solidifies once investors consider YMAB's positive earnings outlook. For the current quarter, no earnings estimate has been cut compared to 2 revisions higher in the past 60 days. The Zacks Consensus Estimate has increased too.Investors may want to watch YMAB for more gains in the near future given the company's key technical level and positive earnings estimate revisions.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Y-mAbs Therapeutics, Inc. (YMAB): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: NOW und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf NOW

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf NOW

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu NOW Inc When Issued

Wer­bung

Analysen zu NOW Inc When Issued

DatumRatingAnalyst
05.08.2019NOW Market PerformCowen and Company, LLC
03.08.2018NOW BuyStifel, Nicolaus & Co., Inc.
03.08.2018NOW Market PerformCowen and Company, LLC
03.05.2018NOW Market PerformCowen and Company, LLC
15.02.2018NOW BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
03.08.2018NOW BuyStifel, Nicolaus & Co., Inc.
15.02.2018NOW BuyStifel, Nicolaus & Co., Inc.
16.01.2018NOW BuyStifel, Nicolaus & Co., Inc.
06.06.2017NOW BuyStifel, Nicolaus & Co., Inc.
04.05.2017NOW BuySeaport Global Securities
DatumRatingAnalyst
05.08.2019NOW Market PerformCowen and Company, LLC
03.08.2018NOW Market PerformCowen and Company, LLC
03.05.2018NOW Market PerformCowen and Company, LLC
15.02.2018NOW Market PerformCowen and Company, LLC
02.11.2017NOW Market PerformCowen and Company, LLC
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für NOW Inc When Issued nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen